local_hospital

Area De Salud De Salamanca

Address
Paseo De San Vicente 55-182, 37007 Salamanca, Spain

Area De Salud De Salamanca - Cardiovascular Research Center

Area De Salud De Salamanca is a distinguished clinical research institution specializing in advanced cardiovascular medicine and therapeutic interventions. The center demonstrates particular expertise in structural heart disease, preventive cardiology, and innovative treatment strategies for complex cardiac conditions.

  • Hypertrophic cardiomyopathy research, including novel pharmacological interventions and cardiac imaging studies using magnetic resonance technology
  • Atherosclerotic cardiovascular disease prevention, focusing on lipid-lowering therapies and reduction of major adverse cardiac events
  • Atrial fibrillation management and left atrial appendage closure procedures, with emphasis on optimizing antithrombotic strategies

The research center is actively engaged in multicenter trials evaluating cutting-edge cardiovascular therapeutics and interventional techniques. Their clinical portfolio includes investigations into mavacamten for obstructive hypertrophic cardiomyopathy, inclisiran for secondary prevention in patients with established vascular disease, and optimization of post-procedural anticoagulation protocols following cardiac device implantation. This comprehensive approach positions Area De Salud De Salamanca at the forefront of cardiovascular research, contributing valuable evidence to improve outcomes for patients with diverse cardiac pathologies.

Site Overview

assignment
3
connected trials
corporate_fare
3
sponsors
science
10
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
2
Sponsors (total)
3
Active sponsors
2

Sponsor Network

Top 2 by active trials.

lock +1 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 567 other sites in Spain

description
Trial volume
3
Outperforms 58% of sites
public
Therapeutic diversity
1areas
Outperforms 1% of sites
groups
Sponsor diversity
3sponsors
Outperforms 61% of sites

Therapeutic Area Benchmark — Spain

Select a therapeutic area to compare against other sites in Spain.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Spain

Market Share

Country: Spain

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Area De Salud De Salamanca

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Comparative Study of Short-Term Dabigatran Etexilate Versus Antiplatelet Therapy in Preventing Device Thrombosis Post-Left Atrial Appendage Closure in Atrial FibrillationCentre Hospitalier Universite De LavalPhase IIINot Yet Recruiting

IMP list

lock Showing 1 of 10 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Acetylsalicylic Acid1Unknown

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.